123 related articles for article (PubMed ID: 15681897)
1. Absorption and metabolic extraction of diltiazem from the perfused rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2004 Dec; 19(6):430-7. PubMed ID: 15681897
[TBL] [Abstract][Full Text] [Related]
2. First-pass metabolism of 5-fluorouracil in the perfused rat small intestine.
Gu J; Yuasa H; Hayashi Y; Watanabe J
Biol Pharm Bull; 1998 Aug; 21(8):871-3. PubMed ID: 9743260
[TBL] [Abstract][Full Text] [Related]
3. Metabolic extraction of nifedipine during absorption from the rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2002; 17(6):546-53. PubMed ID: 15618710
[TBL] [Abstract][Full Text] [Related]
4. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum.
Johnson BM; Chen W; Borchardt RT; Charman WN; Porter CJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):151-8. PubMed ID: 12649363
[TBL] [Abstract][Full Text] [Related]
5. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
6. Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine.
Kato R; Yuasa H; Inoue K; Iwao T; Tanaka K; Ooi K; Hayashi Y
Drug Metab Pharmacokinet; 2007 Apr; 22(2):96-102. PubMed ID: 17495416
[TBL] [Abstract][Full Text] [Related]
7. Absorption barriers in the rat intestinal mucosa: 1. Application of an in situ perfusion model to simultaneously assess drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):982-98. PubMed ID: 19746412
[TBL] [Abstract][Full Text] [Related]
8. Intestinal first-pass metabolism of eperisone in the rat.
Mihara K; Matsumura M; Yoshioka E; Hanada K; Nakasa H; Ohmori S; Kitada M; Ogata H
Pharm Res; 2001 Aug; 18(8):1131-7. PubMed ID: 11587484
[TBL] [Abstract][Full Text] [Related]
9. Carrier-mediated transport of glycerol in the perfused rat small intestine.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Biol Pharm Bull; 2006 Apr; 29(4):785-9. PubMed ID: 16595918
[TBL] [Abstract][Full Text] [Related]
10. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
[TBL] [Abstract][Full Text] [Related]
11. First-pass metabolism of diltiazem in anesthetized rabbits: role of extrahepatic organs.
Lefebvre M; Homsy W; Caillé G; du Souich P
Pharm Res; 1996 Jan; 13(1):124-8. PubMed ID: 8668661
[TBL] [Abstract][Full Text] [Related]
12. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
13. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats.
Ohnishi N; Kusuhara M; Yoshioka M; Kuroda K; Soga A; Nishikawa F; Koishi T; Nakagawa M; Hori S; Matsumoto T; Yamashita M; Ohta S; Takara K; Yokoyama T
Biol Pharm Bull; 2003 Sep; 26(9):1315-20. PubMed ID: 12951478
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of diltiazem absorption in the rat gastrointestinal tract.
Hikal AH; Anderson CY
Arzneimittelforschung; 1992 Feb; 42(2):101-2. PubMed ID: 1610413
[TBL] [Abstract][Full Text] [Related]
15. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites.
Silberberg M; Morand C; Mathevon T; Besson C; Manach C; Scalbert A; Remesy C
Eur J Nutr; 2006 Mar; 45(2):88-96. PubMed ID: 15981077
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic assay for diltiazem in small-volume blood specimens and application to pharmacokinetic studies in rats.
Scully P; Meehan E; Kelly JG
J Chromatogr A; 1996 Apr; 729(1-2):297-300. PubMed ID: 9004953
[TBL] [Abstract][Full Text] [Related]
17. Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.
Zhao P; Lee CA; Kunze KL
Drug Metab Dispos; 2007 May; 35(5):704-12. PubMed ID: 17293381
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P-gp Inhibition.
Athukuri BL; Neerati P
Phytother Res; 2017 Sep; 31(9):1441-1448. PubMed ID: 28766866
[TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin.
Hong SP; Yang JS; Han JY; Ha SI; Chung JW; Koh YY; Chang KS; Choi DH
J Pharm Pharmacol; 2011 Jan; 63(1):129-35. PubMed ID: 21189658
[TBL] [Abstract][Full Text] [Related]
20. The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit.
Homsy W; Caillé G; du Souich P
Pharm Res; 1995 Nov; 12(11):1722-6. PubMed ID: 8592676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
